siRNA能抑制特定致癌基因表达，展现出较好的抗肿瘤潜力。然而其临床应用面临多重障碍，如负电荷亲水性阻碍细胞摄取，溶酶体逃逸能力不足导致降解风险，肿瘤靶向性差以及易被肾脏快速清除。尤其在治疗脑胶质瘤时，传统药物递送系统还面临血脑屏障的巨大挑战。因此， ...

Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of Directors Dr. Jonathan Stein Appointed CNSide Medical Director AUST ...